Showing results (101-110 of 223) with videos related to
Sort By:
Pageof 23
Nature Reviews. Gastroenterology & Hepatology|January 25, 2023
Immunology and immunotherapy of cholangiocarcinomaTim F Greten, Robert Schwabe, Nabeel Bardeesy, et al.Nature Reviews. Gastroenterology & Hepatology|January 29, 2021
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinomaJosep M Llovet, Thierry De Baere, Laura Kulik, et al.Nature Reviews. Clinical Oncology|September 19, 2023
Biomarkers for immunotherapy of hepatocellular carcinomaTim F Greten, Augusto Villanueva, Firouzeh Korangy, et al.Cancer Letters|August 11, 2025
Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancersChi Ma, Joy A Awosika, Cecilia Monge, et al.Hepatology (Baltimore, Md.)|September 15, 2019
Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum RetentionBryan D Fleming, Daniel J Urban, Matthew D Hall, et al.Immunology|February 7, 2012
S100A9 a new marker for monocytic human myeloid-derived suppressor cellsFei Zhao, Bastian Hoechst, Austin Duffy, et al.Gastroenterology|November 28, 2002
Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesisFlorian R Greten, Christoph K Weber, Tim F Greten, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinomaFirouzeh Korangy, Lars A Ormandy, Jörg S Bleck, et al.Gastroenterology|May 20, 2008
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cellsBastian Hoechst, Lars A Ormandy, Matthias Ballmaier, et al.Oncoimmunology|November 22, 2012
Primary sterile necrotic cells fail to cross-prime CD8(+) T cellsJaba Gamrekelashvili, Lars A Ormandy, Markus M Heimesaat, et al.Pageof 23